Page 1703 - Clinical Small Animal Internal Medicine
P. 1703
Index 1641
surgical, traumatic, and bite wound urine specific gravity (USG) 66–68 urine culture 1132–1133
VetBooks.ir urinary tract infections 1190, 1192 urogenital Mycoplasma urticaria 1413–1414, 1414, 1414
urinology 351
infections 1031
USDA see United States Department of
urolithiasis 1132
Agriculture
infections 933
urinary antiseptics 1194 urolithiasis 1123–1156 USG see urine specific gravity
urinary incompetence 1182–1184, acute kidney injury 1093 USMI see urethral sphincter
1184, 1185 bloodwork 1133 mechanism incompetence
urinary tract 744 calcium phosphate urolithiasis uterine tumors 1317–1318
urinary tract infections 1129–1130, 1142–1143 UTI see urinary tract infections
(UTI) 1189–1195 concepts and definitions 1123 UUT see upper urinary tract
ancillary therapies 1194 cystine urolithiasis 1130–1131, uveal melanocytoma/melanoma
asymptomatic bacteriuria 1191 1134, 1136, 1143 1264, 1264
classifications of UTI 1191–1192 diagnosis 1132–1136 uveitis 909
complicated UTIs 1194 educated guesses 1135–1136, 1136 uveodermatologic syndrome
diagnosis 1190 history and physical 1430–1431, 1487–1488
epidemiology/signalment 1189 examination 1123–1124
etiology/pathophysiology imaging of the urinary tract v
1189, 1191 1134–1135, 1134–1135 VA see ventricular arrhythmias
fungal infections 997–998 mechanisms of urolith vaccination 1567–1570
history and clinical formation 1123, 1124 anthrax 974–975
signs 1189–1190 medical management of lower antigen delivery systems
micturition and associated urinary tract stones 1568–1569
disorders 1187 1136–1144, 1140 canine distemper virus 853
nocosomial and multidrug‐resistant medical management of canine herpesvirus 856
infections 1058–1060 upper urinary tract canine infectious respiratory disease
prognosis 1195, 1195 stones 1149–1150 complex 1037
recurrent UTIs or mixed/compound canine parvovirus type 2 859
reinfections 1191–1192 uroliths 1143–1144 clinical decision making 21–23
spinal cord injury 747 other types of urolithiasis feline coronavirus 875
treatment 1192–1195 1131–1132, 1131–1132, feline immunodeficiency virus 884
uncomplicated UTIs 1191, 1143–1144 feline leukemia virus 880–881
1193–1194 oxalate urolithiasis 1093, feline parvovirus 870
urethral obstruction 1114 1124–1127, 1126, 1137–1139 feline viral upper respiratory tract
urolithiasis 1124, 1128, 1133, 1136, purine urolithiasis 1128–1129, disease 889
1149–1150 1128 immune system response to
urinary tract tumors 1307–1310 recurrence prevention disease 1567–1568
bladder tumors 1307–1308, 1309 strategies 1138–1144, 1140 infectious vaccines 1568–1569
diagnosis/staging removal of lower urinary tract kennels and multicat
1307–1309, 1309 uroliths 1144–1149, environments 1064
epidemiology 1307, 1309 1145–1146, 1146, 1148 leptospirosis 948
etiology/pathophysiology removal of upper urinary tract Lyme borreliosis 942, 943
1307, 1309 uroliths 1149–1156, 1152, 1153, melanoma 1349–1350, 1350
history and clinical signs 1154, 1156 modified live vaccines 1569
1307, 1309 signalment by stone type noninfectious vaccines 1568
renal tumors 1309–1310 1124–1132, 1125, 1126 oral cavity and salivary glands 539
signalment 1307, 1309 silicate urolithiasis 1131, 1143 oral tumors 1255
treatment and prognosis specific tests to detect cystinuric papillomaviruses 863
1308–1309 dogs 1134 protozoal and protozoa‐like
urethral tumors 1309 stone analysis 1133–1134, 1133 infections 1011
urine aldosterone to creatinine ratio struvite urolithiasis 1127–1128, rabies 892–897
(UACR) 91 1127, 1136, 1139–1141 reasons for failures 1569–1570
urine cortisol to creatinine ratio ureteral obstruction 1117–1119, recombinant vector vaccines 1569
(UCCR) 53–54, 54–56 1121–1122 soft tissue sarcomas 1333,
urine protein:creatinine ratio urethral obstruction 1109–1110, 1337–1338
(UPC) 1102–1105, 1165, 1166 1115 West Nile virus 900
urine sediment 1132, 1190 urinalysis 1132 yersiniosis 953–954